Elaitra Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
4
- Latest Deal Type
-
Accelerator/Inc
- Latest Deal Amount
-
$25K
- Investors
-
6
Elaitra General Information
Description
Developer of a digital breast tomosynthesis imaging technology designed to detect breast cancer with 3D artificial intelligence. The company offers a viewing assistant and computer-assisted diagnosis and detection for triage and solves detection's worst pain-points, enabling doctors to detect and treat cancer at an early stage.
Contact Information
Website
www.elaitra.comCorporate Office
- 1 Lambeth Palace Road
- Becket House
- London SE1 7EU
- England, United Kingdom
Corporate Office
- 1 Lambeth Palace Road
- Becket House
- London SE1 7EU
- England, United Kingdom
Elaitra Timeline
Elaitra Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Accelerator/Incubator | 30-Jan-2024 | $25K | Completed | Generating Revenue | ||
| 6. Later Stage VC | 22-May-2023 | Completed | Generating Revenue | |||
| 5. Accelerator/Incubator | 13-Jul-2022 | Completed | Startup | |||
| 4. Later Stage VC | 21-Feb-2022 | Completed | Startup | |||
| 3. Seed Round | Completed | Startup | ||||
| 2. Grant | 01-Dec-2021 | $38.8K | Completed | Startup | ||
| 1. Grant | 01-Feb-2019 | $247K | Completed | Startup |
Elaitra Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | 8,888 | $0.000125 | $2.81 | $2.81 | 1x | $2.81 | 0.67% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Elaitra Signals
Elaitra Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Alchemist Accelerator | Accelerator/Incubator | |||
| SFC Capital | Venture Capital | Minority | ||
| Cancer Tech Accelerator | Accelerator/Incubator | |||
| Innovate UK | Government | |||
| Cancer Research Technology | Venture Capital | Minority |
Elaitra FAQs
-
When was Elaitra founded?
Elaitra was founded in 2015.
-
Where is Elaitra headquartered?
Elaitra is headquartered in London, United Kingdom.
-
What is the size of Elaitra?
Elaitra has 4 total employees.
-
What industry is Elaitra in?
Elaitra’s primary industry is Diagnostic Equipment.
-
Is Elaitra a private or public company?
Elaitra is a Private company.
-
What is Elaitra’s current revenue?
The current revenue for Elaitra is .
-
How much funding has Elaitra raised over time?
Elaitra has raised $1.28M.
-
Who are Elaitra’s investors?
Alchemist Accelerator, SFC Capital, Cancer Tech Accelerator, Innovate UK, and Cancer Research Technology are 5 of 6 investors who have invested in Elaitra.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process